Skip to content Skip to navigation

Drug Discovery

EMD Serono
EMD Serono
45 A Middlesex Turnpike Billerica, MA 01821 USA

EMD Serono, Inc. is a leader in the biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve patients' lives. Focusing on specialized areas including neurodegenerative diseases, fertility, metabolic endocrinology, as well as oncology as an emerging area of expertise, EMD Serono is committed to discovering and developing innovative products that meet unmet medical needs.

CombinatoRx Incorporated
CombinatoRx Incorporated
245 First Street Cambridge, MA 02142 USA

CombinatoRx, Incorporated is pioneering the new field of synergistic combination pharmaceuticals. Going beyond traditional combinations, CombinatoRx creates product candidates with novel mechanisms of action striking at the biological complexities of human disease.

Charm Sciences Inc
Charm Sciences Inc
659 Andover St Lawrernce, MA 01843 USA

Charm Sciences is a world leading provider of food safety diagnostic tests custom manufactured to meet an ever-changing global regulatory environment. Over the years, Charm has extended its diagnostic portfolio to include test kits and integrated programs for antibiotics, mycotoxins, pesticides, alkaline phosphatase, pathogens, end-product microbial assessment, allergen control, and ATP.

Bruker Daltonics Inc.
Bruker Daltonics Inc.
40 Manning Rd Billerica, MA 01821 USA

Bruker Daltonics is a pioneer and leader in providing enabling life science tools based on mass spectrometry for the post-genomic revolution

Biogen Idec Inc
Biogen Idec Inc
14 Cambridge Center Cambridge, MA 02142 USA

Biogen Idec Inc. is focused on developing treatments in the areas of oncology, immunology, and neurology. Its product roster includes best-selling Avonex, the most popular drug for the treatment of relapsing multiple sclerosis.

U. S. Genomics, Inc.
U. S. Genomics, Inc.
6 Gill Street Woburn, MA 01801 USA

U.S. Genomics has pioneered commercial applications of single molecule DNA, RNA and protein analysis. The company's innovative technologies which include proprietary technologies for extraction of high grade DNA from complex samples, tagging, microfluidics and genomic mapping, address high value unmet needs in bio-security, human diagnostics, and food and drug contaminant monitoring.

Triton Systems, Inc
Triton Systems, Inc
200 Turnpike Road Chelmsford, MA 01824 USA

Triton Systems incubates and co-funds materials-inspired products. Triton Systems is leading applied research and development company dedicated to creating products and processes for the US government and commercial markets. We now have evolved into an integrated applied R&D and product development firm with a technology venturing arm and a global expertise in myriad of markets.

SRU Biosystems
SRU Biosystems
14A Gill Street Woburn, MA 01801 USA

SRU Biosystems is a global provider of novel, label-free, detection tools used in drug discovery and life sciences research. Our patented BIND® technology rapidly analyzes biomolecular interactions of cells, proteins, genomic materials, peptides, antibodies and small molecule compound libraries. BIND technology represents a fundamental advance in the ability to monitor label-free biological interactions with high sensitivity and high throughput.

Network Biosystems, Inc.
Network Biosystems, Inc.
1-B Gill Street Woburn, MA 01801 USA

Network Biosystems, Inc. is the leading provider of the full set of technologies and products for the emerging field of Rapid DNA Analysis (RDA). RDA enables the identification (by fragment sizing or nucleic acid sequencing) of the most informative subset of a given human or pathogen genome, allowing end users to make decisions in real time.

Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc.
840 Memorial Drive Cambridge, MA 02139 USA

Mersana Therapeutics employs its biodegradable polymer platform (Fleximer®) to create new and better medicines. We are advancing our own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. We also leverage the versatility of Fleximer through partnerships to overcome the safety, efficacy, and delivery challenges of nucleic acids, biologics, and small molecules in numerous therapeutic areas.

Pages